The Enantiomics of Emerging Contaminants

$17.50 plus tax (Refund Policy)

Buy Article:

Abstract:

The beta-blocker pharmaceuticals propranolol and metoprolol are administered as racemates. In municipal wastewater treatment plants, propranolol underwent apparent enantioelective degradation during biological treatment. As a result, EF values for propranolol greater than 0.48 in surface water samples are indicative of raw sewage sources (e. g., leaking sewers, combined sewer overflows) while values below 0.45 are indicative of wastewater effluent sources and could be used for source identification. Metoprolol EF values did not change appreciably during wastewater treatment, with EF values in effluent ranging from 0.47 to 0.53 in wastewater effluent. However, in effluent-receiving waters, the EF values decreased as the compounds undergo biotransformation. In the Trinity River, an effluent-dominated river with a travel time of approximately two weeks, the concentrations of metoprolol decreased by over 90% and the EF values decreased to less than 0.35 as the water moved downstream.

Keywords: Beta-blocker; Chiral; Natural Attenuation; Sewer Overflow

Document Type: Research Article

DOI: http://dx.doi.org/10.2175/193864707786542652

Publication date: July 29, 2007

More about this publication?
  • Proceedings of the Water Environment Federation is an archive of papers published in the proceedings of the annual Water Environment Federation® Technical Exhibition and Conference (WEFTEC® ) and specialty conferences held since the year 2000. These proceedings are not peer reviewed.

    WEF Members: Sign in (right panel) with your IngentaConnect user name and password to receive complimentary access.
  • Subscribe to this Title
  • Membership Information
  • About WEF Proceedings
  • WEFTEC Conference Information
  • ingentaconnect is not responsible for the content or availability of external websites

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more